Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
Clinical trial NCT05799651 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05799651
- Sponsor
- Glycovax Pharma Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2024-06-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.